Ozagrel (sodium), CAS [[189224-26-8]]

Produktübersicht

• Artikelname: Ozagrel (sodium), CAS [[189224-26-8]]
• Artikelnummer: MCE-HY-B0428A
• Hersteller Artikelnummer: HY-B0428A
• Alternativnummer: MCE-HY-B0428A-5MG,MCE-HY-B0428A-100MG,MCE-HY-B0428A-50MG,MCE-HY-B0428A-10MG,MCE-HY-B0428A-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: OKY-046 (sodium)

Produktbeschreibung

Ozagrel sodium (OKY-046 sodium) is a high selective and orally active thromboxane A2 (TXA2) synthase inhibitor with an IC50 of 11 nM. Ozagrel sodium exerts anti-platelet aggregation, vasodilation and anti-inflammatory effects by inhibiting the production of TXA2 and increasing the production of prostacyclin (PGI2). Ozagrel sodium can be used for the study of ischemic stroke, asthma and thromboembolic diseases[1][2][3][4][5].

Produkteigenschaften

• Molekulargewicht: 250.23
• Reinheit: 99.82
• CAS Nummer: [189224-26-8]
• Formel: C13H11N2NaO2
• Target-Kategorie: Prostaglandin Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound